authors
- Chu, QS-C
- van Herpen, C
- Leighl, NB
- Markman, B
- Clarke, S
- Juergens, Rosalyn
- Basciano, P
- Lathers, D
- Tannenbaum-Dvir, S
- Urbanska, K
- Kollia, G
- Darby, C
- Williams, D
- Kolaitis, G
- Ready, N
Initial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in combination with nivolumab, in pts with relapsed/refractory (rel/ref) small-cell lung cancer (SCLC)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2017
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal